Let's talk. #LARVOL

Recently, the U.S. FDA approved durvalumab with pt-containing chemotherapy as neoadjuvant treatment, followed by single-agent durvalumab after surgery in NSCLC lacking which mutations? #LARVOL #Oncology #CancerResearch #Neoadjuvant #OncologyUpdates #FDA #CancerCare #Durvalumab

Recently, EU approved Imfinzi (durvalumab) with the PARP inhibitor Lynparza (olaparib) as a maintenance treatment for which of the following? #LARVOL #CancerResearch #Oncology #Imfinzi #Lynparza #EuropeanUnion #CancerTreatment #CancerCare

LARVOL is looking forward to Pharma CI Conference USA in Newark, NJ, from September 25-26, 2024! ✨ Our team will also be presenting on “Using AI to Predict Trial Completion and Outcome in Oncology Trials.” We look forward to sharing insights on the impact of AI in oncology research.

#LARVOL

Big news in precision medicine! 📰 The EU has approved Rybrevant (amivantamab) with chemo for adults with advanced NSCLC and certain EGFR mutations, after prior therapies, including EGFR TKIs, have failed. A major step forward in personalized cancer treatment! 🌟

Top GI Cancer News Analytics - August 2024 Discover the most discussed topics by leading oncologists on X. Stay ahead in the rapidly evolving field of oncology with LARVOL CLIN: bit.ly/4da5h1k #LARVOL #Oncology #GICancer #CancerResearch #OncologyUpdates

Top GU Cancer News Analytics - August 2024 Dive into the most talked-about GU cancer news, analyzed by the leading oncologists on X. Stay ahead in oncology with LARVOL CLIN. Explore now 👉 bit.ly/4da5h1k #LARVOL #Oncology #GUCancer #CancerResearch #OncologyUpdates

Top Lung Cancer News Analytics - August 2024 Explore the most discussed topics by leading oncologists on X! Stay ahead of the curve with the latest insights in lung cancer with LARVOL CLIN 👉 bit.ly/4da5h1k #LARVOL #Oncology #CancerResearch #LungCancer

Stay tuned for this week's LARVOL Onco Data Podcast with Wafik S. El-Deiry, MD, PhD, FACP.

This week, on LARVOL Onco Data Podcast, we have a special guest, Wafik S. El-Deiry, MD, PhD, FACP who will be in conversation with our host Mark Grambling, to discuss the latest trends in #PrecisionOncology. #LARVOL #OncoDataPodcast #Oncology #CancerResearch #CancerCare #OncologyUpdates

As we head towards the WCLC-IASLC 2024, LARVOL CLIN is excited to spotlight the top trials and key reactions from leading oncologists on X! Stay ahead with the latest pre-IASLC-WCLC 2024 insights: bit.ly/4dRZLRg #LARVOL #WCLC24 #Oncology #CancerResearch #CancerData

As IASLC-WCLC 2024 is around the corner, LARVOL CLIN has curated a list of top oncologists on X who are actively sharing their insights on #LungCancer research. Get the latest pre-IASLC WCLC 2024 trends in oncology: bit.ly/4dRZLRg #LARVOL #Oncology #WCLC24

Join us this Sunday, Sep 8, from 6:00-7:30 PM PST at WCLC 2024 in San Diego for our latest research on metastatic NSCLC treatment strategies! 🫁💫 We’re diving into new data on ADCs and their potential to transform outcomes in the 2L+ setting. Want more details? Head to our blog

New in oncology this week: A new targeted treatment has just been approved in the EU for advanced lung cancer with a specific mutation. 💫 Exciting step forward for patients! #Oncology #CancerTreatment #CancerResearch #CancerNews #PrecisionMedicine #LARVOL

As we approach the WCLC-IASLC 2024, LARVOL CLIN is spotlighting the top trials based on leading oncologists' reactions on X! Stay ahead with the latest pre-IASLC-WCLC 2024 insights: bit.ly/4dRZLRg #LARVOL #WCLC24 #LungCancer #Oncology

Top Heme-Onc News Analytics - August 2024 Discover the most talked-about topics in hematologic cancer, as discussed by leading oncologists on X . Stay updated with the latest insights that are shaping the future of oncology with LARVOL CLIN: bit.ly/4da5h1k #LARVOL

@LARVOL Onco Data Podcast with Wafik S. El-Deiry, MD, PhD, FACP and Dr. Mark Gramling x.com/i/broadcasts/1…

The ESMO - Eur. Oncology 2024 is just around the corner, and the Regular Abstracts (Mini Oral, Proffered Paper, Posters) have just been released! Stay tuned with us for the latest updates from #ESMO24! #LARVOL #Oncology #CancerResearch #OncologyUpdates #CancerData #CancerCare